UTAH MEDICAL PRODUCTS INC (UTMD) Institutional Buying Activity

Institutional investors tracked by InsiderSet increased exposure to UTAH MEDICAL PRODUCTS INC (UTMD) during the quarter ended March 31, 2026 through a combination of new purchases and expanded existing positions disclosed in SEC Form 13F filings.

The largest institutional buyer of UTMD during the latest reporting period was Sequoia Financial Advisors, which increased its reported UTMD position by approximately $307,126 based on quarter-end filing values. Several additional hedge funds and long-term asset managers also reported meaningful increases in UTMD exposure during the quarter.

Institutional buying activity can provide insight into investor conviction, sector allocation trends, and smart money positioning toward UTAH MEDICAL PRODUCTS INC (UTMD). InsiderSet tracks quarterly accumulation trends, new institutional positions, ownership increases, and estimated performance of newly disclosed holdings using SEC filing data and recent market prices.

The investors highlighted on this page collectively added approximately $586,193.692 in reported UTMD exposure during the latest filing period, reflecting continued institutional interest in UTAH MEDICAL PRODUCTS INC's growth initiatives and strategic positioning.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q3 2024Renaissance Technologies LLCBuy3,500230,614$15,430,383
Q2 2024Sequoia Financial AdvisorsBuy4,5974,597$307,126
Q1 2024Renaissance Technologies LLCBuy27,900232,514$16,534
Q3 2023Renaissance Technologies LLCBuy2,122205,514$17,674
Q2 2022Renaissance Technologies LLCBuy3,656227,370$19,531
Q1 2022Renaissance Technologies LLCBuy800223,714$20,103
Q4 2020Renaissance Technologies LLCBuy6,923247,737$20,884
Q3 2020Renaissance Technologies LLCBuy7,100240,814$19,234
Q2 2020Renaissance Technologies LLCBuy2,200233,714$20,712
Q2 2019Renaissance Technologies LLCBuy10,266248,514$23,783
Q3 2018Renaissance Technologies LLCBuy31,661250,583$23,605
Q1 2018Renaissance Technologies LLCBuy6,722218,922$21,640
Q4 2017Renaissance Technologies LLCBuy18,900212,200$17,273
Q3 2017Renaissance Technologies LLCBuy26,755193,300$14,217
Q2 2017Renaissance Technologies LLCBuy21,845166,545$12,058
Q1 2017Renaissance Technologies LLCBuy7,700144,700$9,015
Q4 2016Renaissance Technologies LLCBuy2,000137,000$9,967
Q3 2016Renaissance Technologies LLCBuy4,500135,000$8,073
Q2 2016Renaissance Technologies LLCBuy6,769130,500$8,222
Q1 2016Renaissance Technologies LLCBuy14,731123,731$7,738
Q4 2015Renaissance Technologies LLCBuy14,200109,000$6,381
Q3 2015Renaissance Technologies LLCBuy2,40094,800$5,107
Q2 2015Renaissance Technologies LLCBuy2,40092,400$5,510
Q1 2015Renaissance Technologies LLCBuy1,30090,000$5,387
Q4 2014Renaissance Technologies LLCBuy1,00088,700$5,326
Q3 2014Renaissance Technologies LLCBuy40087,700$4,276
Q2 2014Renaissance Technologies LLCBuy7,00087,300$4,491
Q1 2014Renaissance Technologies LLCBuy4,90080,300$4,644
Q4 2013Renaissance Technologies LLCBuy7,30075,400$4,310
Q3 2013Renaissance Technologies LLCBuy13,40068,100$4,048

Frequently asked questions about UTMD activity

  • Which institutional owners are buying UTMD?

    Institutional owners buying UTMD include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in UTMD activity?

    "Buy" means an investor increased their reported position in UTMD compared to the prior reporting period. This reflects growing exposure to UTAH MEDICAL PRODUCTS INC (UTMD) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in UTMD increasing?

    Institutional interest in UTMD can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.